Outcome of Radiation Therapy in Operated Gastric Cancer
Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04810663
Collaborator
(none)
40
24
Study Details
Study Description
Brief Summary
-
Study tolerability and toxicity of radiotherapy with or without chemotherapy for operated gastric cancer.
-
Evaluate the efficacy of adjuvant radiotherapy with or without chemotherapy as regarding local control and overall survival.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
40 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Outcome of Radiation Therapy In Operated Gastric Cancer
Anticipated Study Start Date
:
Apr 1, 2021
Anticipated Primary Completion Date
:
Jan 1, 2023
Anticipated Study Completion Date
:
Apr 1, 2023
Outcome Measures
Primary Outcome Measures
- Efficacy of Radiotherapy in operated gastric cancer [Baseline]
Disease Free Survival
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
Age of the patient; ≥18 and ≤75 years.
-
Histologically proven gastric or gastroesophageal adenocarcinoma.
-
Pt received adjuvant Radiotherapy with or without chemotherapy with any protocol.
Exclusion Criteria:
-
Patient >75 years&<18 years.
-
Histologically types other than adenocarcinoma .
-
Metastatic patients (M1).
-
Pt didn't recive radiotherapy.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Mohamed Ahmed Ezzat Mohamed,
principal Investigator,
Assiut University
ClinicalTrials.gov Identifier:
NCT04810663
Other Study ID Numbers:
- Radiotherapy in gastric cancer
First Posted:
Mar 23, 2021
Last Update Posted:
Mar 23, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: